BIO-B Bio-Rad Laboratories, Inc.

389.98USD0.00%Mkt Cap: 10.49B USDP/E: 10.36

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates throug…

Institutional holders8 on file

Key Statistics

Company
Market Cap10.49B USD
Enterprise Value10.19B USD
Revenue (TTM)2.59B USD
Gross Profit1.34B USD
Net Income (TTM)759.90M USD
Revenue/Share96.45 USD
Last Price389.98 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees7.5K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)10.36
P/E (Forward)—
PEG4.23
EV/EBITDA24.79
EV/Revenue3.93
P/S4.05
P/B1.38
EPS (TTM)37.64 USD
EPS (Forward)—
52W Range
—
52W High389.98 USD
52W Low389.98 USD
Profitability
Gross Margin51.87%
Oper. Margin9.46%
EBITDA Margin15.85%
Profit Margin29.42%
ROE10.20%
ROA7.18%
ROIC2.29%
ROCE2.17%
Growth
Revenue Growth0.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF532.20M USD
CapEx (TTM)157.60M USD
FCF Margin10.48%
FCF Yield2.59%
Net Debt-300.90M USD
Net Debt/EBITDA-0.73
Net Debt/FCF-1.11
Balance Sheet
Debt/Equity0.19
Current Ratio3.18
Quick Ratio2.16
Book Value/Sh282.74 USD
Cash/Share61.89 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split2:1
Split DateMar 8, 2002
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.5.06M
Float21.51M
Insiders98.23%
Institutions0.06%
Short Interest
Short Ratio1.0d
Short % Float0.00%
Short % Out.0.00%
Shares Short1
Short (prev mo.)2
Technical
SMA 50369.50 (+5.5%)
SMA 200314.27 (+24.1%)
Beta1.06
S&P 52W Chg12.75%
Avg Vol (30d)39
Avg Vol (10d)20
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—